CMaT2-R-celltherapymfg_fig1
![Summarized results from case studies of cost analysis](https://erc-assoc.org/sites/default/files/styles/page_width/public/CMaT2-R-celltherapymfg_fig1.jpg?itok=o0PI6Org)
Summarized results from case studies of cost analysis show the impact of different gene-transfer methods of CAR-T cost (left) and the impact of automation on iPSC cost (right)
Credit:
CMaT
Related content:
Related center: